T he risk of developing atherosclerosis, the leading cause of death in industrialized countries, is considerably reduced in people with relatively high concentrations of plasma HDL. Although it is unclear how HDL protects against atherosclerosis, it may (1) stimulate reverse cholesterol transport and thereby decrease the deposition of cholesterol in peripheral tissues (including arteries), (2) prevent foam cell formation by inhibiting physical and chemical modifications of LDL, (3) inhibit chronic inflammation in atherogenesis by suppressing the formation of adhesion molecules and macrophage chemotactic proteins (see recent reviews 1, 2 ), (4) reduce lipoprotein retention, and (5) attenuate endothelial dysfunction. Plasma HDL levels are regulated by genes and the environment, and it is believed that up to 70% of the variation in HDL cholesterol (HDL-C) levels among humans is genetically determined (see recent reviews [2] [3] [4] .
Genes controlling HDL metabolism and function can be found either through biochemical studies of occasional natural mutations in humans and other animals or by genetic mapping. However, whereas conventional genetic mapping approaches were designed for single-gene traits, the genes regulating complex quantitative traits such as HDL-C levels are best mapped by using a quantitative trait loci (QTL) approach. 5 Once QTL regions are found and narrowed, candidate genes can be identified and tested. This process has been considerably simplified ever since the human and mouse genomes have been sequenced. When genes are identified in mouse models, their human orthologues can be predicted. Thus, to help researchers identify genes that regulate HDL-C concentrations, we compiled a composite genetic map of the currently mapped QTL and associated candidate genes in mouse models. We also explored the correlation of QTL for HDL-C concentrations in humans with those in mice.
Many genes are already known to regulate either HDL function or metabolism or both (see recent reviews 2-4,6,7 ). Table 1 categorizes these genes into 5 groups that encode (1) HDL-associated apolipoproteins, (2) HDL-associated enzymes and transfer proteins, (3) plasma and cell enzymes that affect HDL, (4) cellular receptors and transporters that interact with HDL, and (5) transcription factors that affect HDL. Table 1 also lists the positions of these genes on mouse and human chromosomes. Besides commonly used inbred stains, some mutant mouse stains were also used as parental strains in an intercross to map QTL for HDL-C levels. 8, 9 In one report, the mutant Fas gene (now renamed Tnfrsf6) may contribute to autoimmunity and abnormal lipid profiles, 9 and in the other report, 8 KK.Cg-A y mice develop diabetes and obesity. Thus, the relationship and interactions of the genes involved in regulating HDL-C levels and those in the respective diseases might be revealed in these crosses.
Although most of the QTL associated with HDL-C concentrations in the present review were resolved by using either intercross or backcross designs, some were detected in recombinant inbred (RI) strains (see Figure 1 for generation of RI strains). In each RI strain set, alleles of unlinked genes that vary between the parental strains are randomized by the accumulation of recombination events that become fixed in successive generations. 10 Alleles at closely linked genes tend to remain linked in the final RI sets. The genetic loci among the strains constituting an RI set have an inheritance pattern known as a strain distribution pattern (SDP). If 2 genes are closely linked, their SDP among the strains of an RI set should be very similar. Because the data are cumulative, a new gene can be mapped by comparing its SDP with the SDPs of polymorphic markers in the RI set. Because RI strains have 4 times the recombination opportunity of standard backcrosses and 2 times the recombination opportunity of standard intercrosses, QTL may be identified in a relatively small number of RI strain sets. In addition, several RI sets have C57BL/6 as 1 of the parental strains: AXB, BXA, BXD, BXH, or CXB (A indicates A/J; B, C57BL/6; D, DBA/2J; H, C3H/HeJ; and C, BALB/cByJ). Therefore, it is possible to collapse all non-B alleles into a single class and combine linkage-likelihood ratios of the component RI sets, 11 making more RI sets available for mapping each QTL.
More recently, the strategy of advanced intercross lines (AILs) was proposed for fine mapping of QTL (see Figure 1 for generation of AILs). 12 We have used this novel approach in narrowing several HDL-C QTL (see below). Although AILs take relatively longer to produce than do backcrosses and intercrosses, only the progeny in the final generation need to be phenotyped and genotyped. Given the same population size and QTL effect, the 95% CI of a QTL map location obtainable from an AIL can be t/2 times smaller than that obtainable from either the same size intercross or backcross scheme (t is the number of the advanced generations). Such fine resolution can even dissect linked QTL. 12 Some have pointed out that the promise of QTL mapping, which was to identify the genes underlying complex common diseases, has not been realized 13 because so few genes underlying the QTL have been identified. The identification of genes has been slow. However, QTL mapping did not really begin until 1989, with the appearance of the Lander and Botstein article 5 ; in 1989 and during the early 1990s, many critical resources were still being developed, such as polymorphic markers, statistical analysis tools, yeast artificial chromosome and bacterial artificial chromosome libraries for constructing a physical map, and expressed sequence tags. The recent availability of the mouse and human genomic sequences and the powerful technology of microarrays for expression studies have just begun to make their impact on QTL mapping. From 1991 through 1998, only 1 or 2 genes were identified per year as the basis of a QTL, but 4 genes were identified in 1999, 6 were identified in 2000, and 13 were identified in 2001. 14 For genes underlying HDL-C QTL, only hepatic lipase has been identified so far. 15, 16 However, a review of the genome locations of QTL and candidate genes, an examination of whether the QTL has been confirmed in multiple studies, and a consideration of whether a QTL is found in a homologous region of the human genome may lead to testable 99 c Physical positions of these genes were retrieved from the Celera database (http://www.celera.com). 100 The closest flanking genes on both sides and at the same BAC or BACs as the gene to be determined were also found in Celera database. cM positions of the flanking genes were retrieved from MGD (http://www.informatics.jax.org). 44 The positions of the flanking genes were used as the position of the gene to be determined. Pafah1b2 maps to the same BACs as Apoa1 and Tagln, both of which are at cM 27 on Chr 9. Pafah1b3 maps to the same BAC as Erf and Lipe, which are at cM 6.0 and cM 5.5, respectively, on Chr 7. Abcg1 maps to the same BACs as Glp1r and Tff3, which are at cM 18 and cM 17, respectively, on Chr 17. Cav maps to the same BACs as Cappa2, which is at cM 3.05 on Chr 6 (Cappa2 is distal to Cav; no gene proximal to Cappa2 is on the same BAC as Cav). Nr1h2: the closest flanking genes of Nr1h2 are Pold1 and Kcn3 on each side. The Celera database does not show the BACs for Pold1 and Kcn3. However, both of them map to cM 23 on Chr 7, and this position is used as the map position of Nr1h2. Nr1h3 maps to the same BACs as Psmc3 and F2, which are at cM 47.0 and cM 47.5, respectively, on Chr 2. d cDNA sequences for these genes were found in NCBI. Homology sequences were found in Celera database by BLASTN, with the chromosomes and physical positions shown there. cM positions were determined as in footnote c above.
Lipg: The position of the homologous sequence of mouse Lipg cDNA is on Chr 18, flanked by Madh4 and Myo5b on either side, both of which are at 48.0 cM on Chr 18. Myo5b is on the same BACs as the homologous sequence of Lipg, and Madh4 is not.
Cubn: The position of the homologous sequence of mouse Cubn is on Chr 2. No known gene proximal to this position is on the same BAC as the homologous sequence of Cubn. The closest distal gene on the same BAC as Cubn is Prkcq, which maps to cM 2.0 on Chr 2.
hypotheses and further experiments to define the genes that regulate HDL-C levels.
HDL-C QTL
Studies of rare human genetic defects, which often result in the total absence of encoded proteins, indicate that APOA1, APOA4, LCAT, CETP, ABCA1, and CUBN (where LCAT is lecithin-cholesterol acyltransferase, CETP is cholesteryl ester transfer protein, ABC is ATP-binding cassette transporter, and CUBN is the gene for cubilin) can regulate HDL-C concentrations, 4 but such rare defects do not account for the variation in HDL-C concentrations in humans. However, more common alleles at these same loci could be responsible. It is especially important to find the genes that are responsible for the common causes of population variance of HDL-C because these are more likely to be effective therapeutic targets. Identifying HDL-C QTL is much easier in mice than in humans for many reasons. Mice can be bred quickly, inexpensively, in strictly controlled environments, and with a variety of inbreeding, intercross, and backcross strategies.
Furthermore, inbred mouse strains have unique genetically defined backgrounds, many of which can be taken advantage of in designing crosses to identify HDL-C QTL. A survey of Ͼ40 inbred mouse strains revealed that some, such as NZB/B1NJ, PERA/CamEi, SPRET/Ei, and BALB/cJ, have relatively high HDL-C concentrations, whereas others, such as SM/J, DBA/2J, SWR/J, and CAST/Ei, have relatively low HDL-C concentrations. [17] [18] [19] Some strains, such as C57BL/6J and C57L, 18, 20, 21 respond to a high-fat diet by decreasing their HDL-C concentrations; others, such as NZB and SM, respond to the same diet by increasing their HDL-C concentrations. 22 We and other research groups have taken advantage of such strain differences in HDL-C concentrations to design crosses identifying QTL associated with HDL-C concentrations (Table 2 [23] [24] [25] [26] [27] [28] ). Altogether, 10 different mouse crosses have been used to detect QTL for HDL-C concentrations: (1) C57BL/6ϫC3H, (2) C57BL/6ϫNZB, (3) C57BL/6ϫ129, (4) C57BL/6ϫCAST/Ei, (5) C57BL/6ϫKK.Cg-A y , (6) A/JϫC57BL/6, (7) NZBϫSM, (8) PERA/EiϫI/Ln, (9) DBA/ 2ϫCAST/Ei, and (10) MRL/MPJ-Tnfrsf lpr ϫBALB/c. Among them, 8 were used in intercrosses, 3 were used in RI strain sets, and 1 was used in AIL. A total of 27 QTL for HDL-C levels were found: 6 of the QTL were detected only in mice fed a chow diet, 10 were detected only in mice fed a high-cholesterol diet, and 11 were detected in mice fed both diets. Thirteen of the 27 QTL were detected with only 1 cross, 8 were detected with 2 different crosses, and 6 were detected with Ն3 different crosses. QTL for HDL-C levels were found on all the mouse chromosomes except for chromosomes 10, 11, 13, and X (Table 2) . We have proposed 40 candidate genes, among which 26 are within the QTL regions for HDL-C concentrations. Because 36% of the mouse genome is covered by the QTL, only 14.4 of the 40 candidate genes would be within the 27 QTL simply by chance, which differs significantly from the 26 candidate genes that were observed (PϽ0.01, 2 test). Figure 2 depicts the chromosomal locations of all the HDL-C QTL and associated candidate genes currently identified in the mouse genome. Each QTL derived from a separate cross (not sharing the same parental strains), as shown in Table 2 , is depicted as a separate bar on the figure even though these may represent the same QTL. For example, the QTL on chromosomes 1, 5, and distal 18 have been replicated independently several times. Some QTL intervals contain genes known to regulate either HDL metabolism or function or both; others do not have obvious candidate genes.
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HDL-Associated Apolipoproteins
Seventy percent of HDL protein consists of apoA-I, whose plasma concentrations are directly correlated with those of HDL-C. Humans with apoA-I deficiency have very little HDL-C and are susceptible to atherosclerosis. 29 Apoa1-targeted mutant mice have abnormally low HDL-C concentrations, and mice transgenic for human APOA1 have abnormally high HDL-C concentrations (see review 30 ). As do Apoa1-targeted mutants, mice with targeted mutations of Apoa4 have lower HDL-C concentrations than do wild-type Figure 1 . Generation of RI strains and AILs. To construct a set of RI strains, mice from 2 inbred progenitor strains were crossed to yield F 1 offspring, which were intercrossed to produce F 2 offspring. Many brother-sister pairs of F 2 mice were mated to produce F 3 offspring, and brother-sister pairs of F 3 mice were mated to produce F 4 offspring, and so on. This brother-sister inbreeding scheme was repeated for 20 generations, so that each pair of F 2 mice gave rise to a unique inbred strain (RI 1 , RI 2 , RI 3 , etc). To generate AILs, mice from 2 inbred progenitor strains were crossed to yield F 1 offspring, which were intercrossed to produce F 2 offspring. Fifty F 2 ϫF 2 matings were made (avoiding brother-sister matings) to produce F 3 offspring, and 50 F 3 ϫF 3 matings were made (avoiding brother-sister and cousin matings) to produce F 4 offspring, and so on, until the desired advanced intercross (F 4 , F 5 , and so on) was attained. Thus, the many recombinations required to narrow a QTL were accumulated in a relatively small population.
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mice. 31 Also, mice transgenic for either human APOA4 32 or mouse Apoa4 33 have higher HDL-C concentrations than do wild-type mice. Clinical studies of human APOA4 are scant. APOA1 and APOA4 are clustered with APOC3, another gene that encodes HDL-associated apolipoproteins, on human chromosome 11q23. The orthologous mouse genes, Apoa1, Apoa4, and Apoc3, cluster on mouse chromosome 9 (cM 27.0, Figure 2 ). Allelic variation in the human gene cluster accounted for 22% of total interindividual variation in plasma HDL-C levels in a study of 73 white nuclear families. 15 An HDL-C QTL identified in a C57BL/6JϫKK-A y intercross colocalizes with the mouse gene cluster (Table 2 and Figure 2 ). This result, combined with the critical role of apoA-I in HDL structure and metabolism, suggests that APOA1 may be an important target for gene-based atherosclerosis therapy.
ApoA-II is the second most abundant structural protein in HDL, constituting 20% of its protein. Whereas transgenic mice carrying the mouse Apoa2 gene have higher HDL-C concentrations than do control mice, 34 transgenic mice carrying the human APOA2 gene have lower HDL-C concentrations than do control mice. 35 This is because human apoA-II, being more hydrophobic than the mouse protein, displaces human apoA-I from HDL, thus decreasing HDL concentrations. Apoa2 maps to mouse chromosome 1 (cM 92.6) and colocalizes with an HDL-C QTL identified in 4 different mouse crosses (C57BL/6ϫC3H, NZBϫSM, C57BL/ 6ϫNZB, and C57BL/6ϫ129) with 4 different approaches (intercross, backcross, RI sets, and AIL; Table 2 ).
Genes Encoding Enzymes and Transfer Proteins That Affect HDL-C Concentrations
Products of several genes dynamically and constantly modify the composition, structure, size, and function of HDL. These include some enzymes directly associated with HDL and plasma or intracellular enzymes that use HDL as substrate (Table 1) . Plasma phospholipid transfer protein (PLTP) is bound to HDL and mediates the net transfer and exchange of phospholipids among different lipoproteins and participates in the transformation of larger HDL 3 into smaller HDL 2 (see recent review 36 ). In mice, PLTP deficiency reduces plasma HDL-C concentrations, 37 whereas moderate overexpression of human 38, 39 or mouse 40 -42 PLTP either increases 38 -40 or decreases 41, 42 plasma HDL-C Table 2 . The size of the QTL was determined as Ϯ10 cM centered around the peak lod score. Candidate genes to the left of the chromosomes are indicated with different colors according to the categories in Table 1 : HDL-associated apolipoproteins (black), HDL-associated enzymes and transfer proteins (red), plasma-and cell-associated enzymes (green), cellular receptors and transporters (blue), and transcription factors (brown). Ath3 is in dark blue. Mouse homologous regions of the human QTL that fall within the HDL-C QTL regions from mouse crosses are represented by asterisks. (Figure 2 ), making Pltp a plausible candidate for this QTL. Hepatic lipase has been identified as an important gene for HDL-C QTL in humans 14, 15 and lies within a mouse QTL as well. Another possible candidate gene is Lipg, which encodes endothelial lipase. Endothelial lipase is synthesized in endothelial cells, macrophages, and hepatocytes and is found in the placenta, thyroid, testes, liver, lungs, kidneys, and spleen. Its sequence is 45% homologous with that of lipoprotein lipase and 40% homologous with that of hepatic lipase. Of the 3, endothelial lipase has the most phospholipase activity and the least triglyceride lipase activity. C57BL/6J mice, APOA1 transgenic mice, and LDL receptor-deficient mice that are transgenic for Lipg all have lower plasma HDL-C concentrations than do control mice. 43 Although the function of endothelial lipase is unknown, it might play an important role in HDL metabolism, possibly by hydrolyzing HDL phospholipids and facilitating selective HDL uptake by scavenger receptor class B type I (SR-BI). 43 After performing a BLASTN search of the Celera database for the physical position of Lipg, we estimated its centimorgan position from the position of its flanking genes in the MGD database 44 (see footnotes in Table 1 for the detailed method). Interestingly, the same chromosome 18 HDL-C QTL identified in 3 different crosses (NZBϫSM intercross, C57BL/ 6JϫC3H intercross, and C57BL/6JϫCAST intercross) colocalizes with the newly found endothelial lipase gene, Lipg 43, 45 ( Table 2 and Figure 2 ).
Cellular Transporters and Receptors
ABC transporters constitute a group of evolutionarily highly conserved cellular transmembrane proteins that act either as active pumps, ion channels, or ATP sensors. 46 The human genome sequence indicates that 51 ABC transporters exist. 47 ABCA1 controls the active transport of cellular cholesterol and phospholipids to lipid-poor apolipoproteins. In humans, ABCA1 mutations affect HDL-C levels 48 and cause Tangier disease, a severe HDL deficiency syndrome characterized by a rapid turnover of plasma apoA-I, accumulation of sterol in tissue macrophages, and atherosclerosis 49 -51 (see recent reviews 7, 52 ). Abca1-deficient mice have extremely low HDL-C levels, 53 and overexpression of ABCA1 in transgenic mice results in elevated apoA-I and HDL-C levels. 54, 55 Abca1 colocalizes with a QTL for HDL-C concentrations to mouse chromosome 4 at cM 23.1 (Figure 2 ), making it an excellent candidate for this QTL. ABCB4, encoded by ABCB4 (MDR3) in humans and Abcb4 (Mdr2) in mice, is a multidrug-resistant gene product. It has a highly restricted transport function, acting as a "flippase" in translocating phosphatidylcholine from the inner to the outer leaflet of the bile canalicular membrane. 56 In Mdr2-targeted mutant mice, besides a complete absence of biliary phospholipid secretion, plasma levels of all classes of lipoproteins were reduced, particularly HDL. 57 The reason is not clear. Therefore, it is interesting to find that Abcb4 colocalizes with an HDL-C QTL on chromosome 5 identified in the (PERA/EiϫI/Ln)F 2 intercross.
Another ABC family member with an undefined role in HDL homeostasis is ABCB11 (bile salt export pump). Abcb11 (chro- Markers with the same superscript on the same chromosome are regarded as within the same QTL. a RI indicates recombinant inbred strains; F2, intercross; BC, backcross; AIL, advanced intercross line. b cM, centimorgan. Genetic distances were retrieved from MGI at http://www.informatics.jax.org. mosome 2, cM 38.4) was shown to be upregulated in macrophages by cholesterol loading and downregulated by cholesterol unloading with HDL 3 in 1 report, 58 although no experimental data were shown in that study. Because of colocalization with an HDL-C QTL (lod score of 5.6) identified in a (C57BL/ 6JϫCAST)F 2 intercross (Table 2 and Figure 2 ), its role in HDL metabolism and atherosclerosis warrants future investigation. In addition to its potential role in HDL metabolism, Abcb11 is also a candidate for the gallstone QTL Lith1 59 (ABCB11 pumps bile salts from hepatocytes to bile canaliculi).
Recently, a polymorphism of ABCC6 60 was found to be associated with variations of HDL-C concentrations in humans. With the same method for mapping Lipg as mentioned above, we mapped mouse Abcc6 to chromosome 7 (cM 24.0), which is within the HDL-C QTL on chromosome 7.
The first HDL receptor was cloned in 1994 (see review 61 ), although several cellular HDL binding sites had been described before. When first cloned, it was named SR-BI because it bound modified LDL (hence, the designation SR) and was the second (hence, the designation B) class of scavenger receptors found. However, it was later found to be primarily an HDL receptor mediating the selective uptake of HDL lipids. Among other functions, SR-BI selectively takes up cholesteryl esters and, under certain conditions, mediates cholesterol efflux from cells. 62 Although Srb1-targeted mutant mice have twice as much HDL-C as do control mice, their susceptibility to atherosclerosis is higher than that of control mice. 63, 64 Conversely, overexpression of Srb1 enhances selective cholesteryl ester uptake and HDL catabolism and severely decreases HDL-C concentrations. 65 Mice overexpressing Srb1 are resistant to atherosclerosis 66, 67 ; however, the protective effect was found in mice with moderately overexpressed Srb1 but was lost in mice with very high level of Srb1 transgene, probably because of the dramatic decrease of HDL cholesterol levels in these mice. 68 An HDL-C QTL identified in 3 crosses (C57BL/6ϫCAST, NZBϫSM, and C57BL/6ϫNZB) colocalizes with Srb1 (chromosome 5, cM 68.0; Table 2 ). However, the coding region of Srb1 had no polymorphic differences between NZB and SM. 27 Furthermore, levels of liver SR-BI mRNA and protein did not differ between NZB and SM strains fed a chow diet. 27 Because the QTL that mapped close to Srb1 was observed in the chow-fed mice from (NZBϫSM)F 2 , these results do not support Srb1 as a candidate gene. The only study of the human orthologue of Srb1, CD36L1 (CD36 and LIMPII analogue 1, which encodes CLA-1), reveals no association between its polymorphisms and plasma HDL-C concentrations. 69 However, the importance of mouse Srb1 in HDL metabolism and in its colocalization with mouse HDL-C QTL in several different crosses justifies more studies on this docking receptor for HDL cholesteryl esters.
CD36, another member of the class B scavenger receptor family, preferentially binds to and takes up moderately oxidized LDL. It also binds to HDL. 70 However, neither overexpression of Cd36 in C57BL/6 mice 71 nor Cd36 deficiency in Apoetargeted mutant mice 72 affects plasma HDL concentrations. Thus, even though Cd36 is in the region of the HDL QTL identified in (PERA/EiϫI/Ln)F 2 , no solid evidence supports it as a promising candidate gene for the QTL.
Transcription Factors
Recent studies have focused on the regulation of Abca1 and Abcg1 because therapies that upregulate them may increase HDL concentrations, promote reverse cholesterol transport, and thereby either prevent or even reverse atherosclerosis. As with Abcg1, Abca1 in macrophages is upregulated by cholesterol loading and downregulated by cholesterol unloading via HDL 3 . 73 Abca1 is activated by the ligands for either or both retinoid X receptors (RXRs [retinoids]) and liver X receptors (LXRs [oxysterols]), 74 -76 which heterodimerize as either LXR␣/RXR or LXR␤/RXR and bind to a DR4 element in the Abca1 promoter. Specifically, LXR␤ binds to DR1 or DR4 elements consisting of direct AGGTCA repeats interrupted by either 1-or 4-nt spacers, respectively, and LXR␣ binds only to DR4 elements whose direct AGGTCA repeats are interrupted by 4-nt spacers. LXR/RXR heterodimers also upregulate Abcg1. 77 The 2 genes encoding these transcription factors, Nr1h3 (Lxra) and Nr1h2 (Lxrb), colocalize with HDL-C QTL on chromosomes 2 and 7, respectively ( Figure  2 ), making them excellent candidates for these QTL. Nr1h2 (Lxrb) may be a more attractive candidate than is Nr1h3 (Lxra) because LXR␤ is more highly expressed in macrophages than is LXR␣ and is clearly more effective than LXR␣ in mediating the sterol response of ABCA1. 74 Because these QTL studies suggest the candidacy of Nr1h3 (Lxra) and Nr1h2 (Lxrb) in HDL metabolism in mice, it will be interesting to discover how the polymorphisms for these genes in humans affect HDL-C concentrations.
The peroxisome proliferator-activated receptors (PPARs) are encoded by members of the nuclear receptor gene family that regulates lipid metabolism, glucose metabolism, and cellular differentiation. Like LXR, they can heterodimerize with RXR. 78 Three Ppar genes have been found and mapped: Ppara (chromosome 15, cM 48.8, encoding PPAR␣), Pparg (chromosome 6, cM 52.7, encoding PPAR␥), and Ppard (chromosome 17, cM 13.5, encoding PPAR␦, also termed PPAR␤). Although macrophages express all 3, the liver mainly expresses PPAR␣, adipose tissue mainly expresses PPAR␥, and many tissues express PPAR␦. PPAR␣ and PPAR␥ activators have been shown to enhance the expression of ABCA1 via the stimulation of Nrlh3 (Lxra). 79, 80 In addition, the agonists for these 2 PPARs enhance the expression of SR-BI/CLA-1, a docking receptor for HDL. 81 In mice transgenic for human APOA1 and in humans, the PPAR␣ agonist fibrate increases plasma HDL-C levels by inducing APOA1 and APOA2 genes in humans and the APOA1 gene in mice. However, in nontransgenic mice, fibrate decreases plasma HDL-C levels by repressing Apoa1 transcription. 82 This opposite regulation of apoA-I expression in humans versus rodents is linked to differences in cis elements in their respective promoters. 82 The PPAR␥ agonist troglitazone also increases serum HDL-C concentrations. 83, 84 Consistent with the roles that PPAR␣ and PPAR␥ play in HDL metabolism, QTL on chromosome 15 for plasma HDL-C levels occur near the Ppara gene in a (NZBϫSM)F 2 cross and are colocalized with the Pparg gene on chromosome 6 in (NZB-LXRϫSM)F 2 and (DBA/ 2ϫCAST/Ei)F 2 crosses (Table 2 and Figure 2) . Recently, GW501516, an agonist specific for PPAR␦, was also found to upregulate Abca1. Additionally, it was found that agonists for PPAR␦ activate Abca1 better than do agonists for PPAR␥ and
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Quantitative Trait Loci for HDL-C Levelsthat agonists for PPAR␥ activate Abca1 better than do agonists for PPAR␣. 85 However, GW501516 did not consistently upregulate LXR, suggesting that alternate mechanisms may contribute to the regulation of ABCA1 expression by PPAR␦ agonists. PPAR␦ agonists have also been found to increase plasma HDL-C concentrations in insulin-resistant C57BLKS-Lepr db /Lepr db mice 86 and in rhesus monkeys. 85 A QTL for HDL-C concentrations in an NZBϫSM intercross colocalizes with Ppard on chromosome 17, 25 which is consistent with the role of PPAR␦ in upregulating ABCA1 and HDL-C levels.
Undiscovered Genes
Our knowledge regarding the pathogenesis of atherosclerosis and the role HDL plays in the process is incomplete. Therefore, some QTL mentioned in the present review do not colocalize with obvious candidate genes. However, the human and mouse genome sequences will greatly facilitate finding those genes that affect HDL-C concentrations and atherosclerosis.
QTL for HDL-C Levels in Humans
So far, 10 published reports exist on genome-wide scans for identification of human QTL that determine HDL-C levels. [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] The results are summarized in Table 3 . To gain further insight into the relevance of the mouse QTL to human studies, we list the mouse chromosome regions homologous to human HDL-C QTL. Interestingly, for 18 of the 22 human HDL-C QTL, at least part of their mouse homologous segments are within QTL for HDL-C levels detected in mouse crosses. Because the mouse HDL-C QTL represent Ϸ36% percent of the genome, it might be possible that the concordance between the QTL for HDL-C levels in the homologous regions of the human and mouse genome is by chance. However, statistically, this is not the case ( 2 test, PϽ0.01). The result of this comparison implies that many of the QTL for HDL-C levels found in humans have homologous counterparts in mice, implying that the QTL may result from common candidate genes. Because more mouse QTL for HDL-C concentrations have been found, possibly as a result of more extensive studies in mice than in humans, additional human chromosome segments that affect HDL-C concentrations can be predicted by the comparative genomic strategy. In this regard, QTL analysis for HDL-C levels in inbred strains of mice provides an immediate as well as Mouse homologous chromosome regions of the human cytogenetic bands were determined according to MGI (www.informatics.jax-.org). 44 It has been checked that the mouse homologous regions of the human cytogenetic band(s) withinϮ5 Mb of the markers (determined according to Celera database; not shown) are on the same mouse chromosome and on the same chromosome region according to the Mammalian Homologous and Comparative Map in MGI, and the Human-Mouse Homologous Map in NCBI (www.ncbi.nlm.nih.gov/Homology/). * Mouse homologous regions of the human QTL that fall within the HDL-C QTL regions (marker with peak LODϮ10 cm) from mouse crosses shown in Table 2 .
long-term guideline and reference for studying genes regulating HDL metabolism and may be used to bridge mouse models and clinical investigations.
Identifying and Proving Candidate Genes
QTL mapping has identified a number of regions that contain genes affecting HDL-C concentrations in mice and humans. The next step is to identify those genes. Several approaches are possible. One is to narrow the QTL region genetically by carrying out crosses in mice until only 1 logical candidate remains or by searching for shared haplotypes in regions of linkage disequilibrium in humans. A second method is to test candidate genes directly. In humans, this can be done by searching for all the common polymorphisms in a gene and its regulatory region and then determining the frequency of each polymorphism in persons that differ in HDL-C concentrations. In mice, this is done by searching for sequence differences between the strains in which the QTL was found. Once a sequence difference in a gene has been found, the investigator has the task of proving that the sequence difference causes a functional difference, so the third method is to test for expression differences in mRNA or protein concentrations. Once an expression difference has been found, the investigator has the task of proving that the quantitative difference in mRNA or protein causes a quantitative difference in the HDL-C concentrations. In mice, this can be done by overexpressing the gene with the use of transgenic technology or by deleting the gene with the use of homologous recombination. Deletion of the gene produces many types of compensatory mechanisms; a better strategy would be to examine the phenotype in a heterozygote of the deleted gene, which would have only a single copy of a functional gene and, thus, theoretically 50% expression. In all these strategies, attention must be paid to the strain background, with strong preference to using the strains that gave the original QTL.
Finally, much of the search so far has focused on differences in HDL-C concentrations. Such a search tests only 1 aspect of the functions of HDL, and important and significant changes in HDL function that result from a change in composition, size, or metabolism might be missed by focusing only on concentrations of HDL-C. These other changes may be critical in determining the risk of developing atherosclerosis. Thus, the final task is to demonstrate that the gene change causing the difference in HDL-C concentrations also alters the development of atherosclerosis.
Notes on Nomenclature
Gene symbols used in the present review follow standard nomenclature for human and mouse genes as defined and updated by the Human Genome Organization (HUGO) Nomenclature Committee 97 and the International Committee on Standardized Genetic Nomenclature in Mice, 98 respectively. As a rule, mouse genes begin with a capital letter and are italicized. Human genes are entirely capitalized and are also italicized. Proteins are entirely capitalized but not italicized.
